1. Research progress on intervention effect and mechanism of protocatechuic acid on nonalcoholic fatty liver disease
- Author
-
Haiyue Liu, Huimin Xue, Jicheng Zhan, Lin Ji, Yilin You, Weidong Huang, Suping Han, Ruizhe Zhang, Rongrong Tian, and Yunxiao Gao
- Subjects
030309 nutrition & dietetics ,Gut flora ,Secondary metabolite ,Bioinformatics ,medicine.disease_cause ,digestive system ,Industrial and Manufacturing Engineering ,Protocatechuic acid ,Anthocyanins ,03 medical and health sciences ,chemistry.chemical_compound ,0404 agricultural biotechnology ,Non-alcoholic Fatty Liver Disease ,Nonalcoholic fatty liver disease ,Hydroxybenzoates ,medicine ,Humans ,0303 health sciences ,biology ,Mechanism (biology) ,business.industry ,nutritional and metabolic diseases ,Cancer ,Lipid metabolism ,04 agricultural and veterinary sciences ,General Medicine ,biology.organism_classification ,medicine.disease ,040401 food science ,digestive system diseases ,Gastrointestinal Microbiome ,Liver ,chemistry ,business ,Oxidative stress ,Food Science ,medicine.drug - Abstract
Nonalcoholic fatty liver disease (NAFLD) has become a surge burden worldwide due to its high prevalence, with complicated deterioration symptoms such as liver fibrosis and cancer. No effective drugs are available for NALFD so far. The rapid growth of clinical demand has prompted the treatment of NAFLD to become a research hotspot. Protocatechuic acid (PCA) is a natural secondary metabolite commonly found in fruits, vegetables, grains, and herbal medicine. It is also the major internal metabolites of anthocyanins and other polyphenols. In the present manuscript, food sources, metabolic absorption, and efficacy of PCA were summarized while analyzing its role in improving NAFLD, as well as the mechanism involved. The results indicated that PCA could ameliorate NAFLD by regulating glucose and lipid metabolism, oxidative stress and inflammation, gut microbiota and metabolites. It was proposed for the first time that PCA might reduce NAFLD by enhancing the energy consumption of brown adipose tissue (BAT). However, the PCA administration mode and dose for NAFLD remain inconclusive. Fresh insights into the specific molecular mechanisms are required, while clinical trials are essential in the future. This review provides new targets and reasoning for the clinical application of PCA in the prevention and treatment of NAFLD.
- Published
- 2021
- Full Text
- View/download PDF